Programme

Sun 25 April 2010
07:00 20:00		Registration

07:00 08:15		Satellite Symposia: Controversial Issues in Acromegaly Faculty presentations will be based on a pre-meeting e-poll Sponsored by Pfizer Room: Forum Hall Chair: Ezio Ghigo (Italy)

08:30 10:00		Symposium 1: European Networks Main Auditorium Chairs: E. Nieschlag (Germany) & J. Christiansen (Denmark)
08:30	S1.1	Endocrinology of the Ageing Male – The European Male Ageing Study (EMAS) F. Wu (UK)
08:45	S1.2	NECTAR - Network for Environmental Chemical Toxicants Affecting Reproduction J. Toppari (Finland)
09:00	S1.3	EUGOGO W. Wiersinga (The Netherlands)
09:15	S1.4	The EuroDSD project and consortium O. Hiort (Germany)
09:30	S1.5	EurAdrenal E. Husebye (Norway)
09:45	S1.6	The European Registry on Cushing’s Syndrome (ERCUSYN) Database: First year experience S. Webb (Spain)

08:30 10:00		Symposium 2: Endocrine aspects of the metabolic syndrome Room: Meeting Hall I Chairs: F. Casanueva (Spain) & TBC
08:30	S2.1	Brain-adipose and brain-liver connections in the metabolic syndrome E. Fliers (The Netherlands)
08:50	S2.2	Combined GH and IGF-1 treatment D. Dunger (UK)
09:10	S2.3	Unacylated ghrelin: a metabolic hormone R. Granata (Italy)
09:30	S2.4	Testosterone treatment in the metabolic syndrome G. Corona (Italy)

08:30 10:00		Symposium 3: Bone Cell Biology Room: Panorama Hall Chairs: P. Broulik (Czech Republic) & J. Payer (Slovakia)
08:30	S3.1	Skeletal stem cells and mechanisms of bone formation M. Kassem (Denmark)
09:00	S3.2	Cross talks between Leptin and the skeleton T. Thomas (France)
09:30	S3.3	The role of the hypothalamic-pituitary-thyroid axis in bone D. Bassett (UK)

10:00 10:15		Coffee Break and Exhibition Room: Exhibition Hall

10:15 11:00		Plenary Lecture 1 Room: Main Auditorium Chairs: M. Alevizaki (Greece) & B. Jarzab (Poland)
10:15	PL1	Twenty years' experience with post-Chernobyl thyroid cancer D. Williams (UK)

11:00 11:15		Presidential Address Room: Main Auditorium

11:15 12:45		Symposium 4: The Ageing Male Room: Main Auditorium Chairs: F. Wu ( UK) & G. Forti (Italy)
11:15	S4.1	Genetic aspects of aging in men I. Huhtaniemi (Finland)
11:45	S4.2	Osteoporosis in the aging male D. Vanderschueren (Belgium)
12:15	S4.3	The natural history of symptomatic androgen deficiency in men: Longitudinal results from the Massachussets Male Aging Study T. Travison (USA)

11:15 12:45		Symposium 5: Novel targets for thyroid cancer treatment Room: Forum Hall Chairs: F. Borson-Chazot (France) & J. Cap (Czech Republic)
11:15	S5.1	Sodium Iodide Symporter C. Spitzweg (Germany)
11:45	S5.2	Molecular mechanisms in thyroid cancer M. Santoro (Italy)
12:15	S5.3	Tyrosine kinase inhibitors in thyroid cancer J. Smit (The Netherlands)

11:15 12:45		Symposium 6: Neuroendocrine control of reproduction Room: Meeting Hall I Chairs: J. Castano (Spain) & R. Millar (UK)
11:15	S6.1	Sexual differentiation of hypothalamic Kiss1 neurons A.S. Kauffman (USA)
11:35	S6.2	KNDy (kisspeptin/neurokinin B/dynorphin) cells of the arcuate nucleus: a central node in the control of GnRH secretion M.N. Lehman (Canada)
11:55	S6.3	Consequences of Non-Classical ERα Signaling in Brain J. Levine (USA)
12:15	S6.4	Insulin regulation of reproductive brain: Rodent and human studies F. Pralong (Switzerland)

11:15 12:45		Oral Communications 1: Diabetes & Obesity Room: Panorama Hall Chairs: V. Hana (Czech Republic) & I. Konrade (Latvia)
11:15	OC1.1	Role of newly identified immunosuppressive NK cells in autoimmunity Presenter: Margret Ehlers M Ehlers; C Papewalis; B Jacobs; A Thiel; S Schinner; H S.Willenberg; W A.Scherbaum; M Schott;
11:30	OC1.2	Glucose insulinotropic peptide (GIP) secretion in Type 2 diabetic and obese non-diabetic persons examined by meal test Presenter: Jan Škrha J Škrha; J Hilgertová; M Jarolímková; M Kunešová; M Hill;
11:45	OC1.3	NME7 - a new candidate gene for T2DM Presenter: Josef Vcelak J Vcelak; O Seda; M Vankova; P Lukasova; J Vrbikova; J Tremblay; B Bendlova; P Hamet;
12:00	OC1.4	The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction Presenter: Giovanni Corona G Corona; V Boddi; G Balercia; R Giulia; G deVita; A Sforza; G Forti; E Mannucci; M Maggi;
12:15	OC1.5	Role of PKA regulatory subunit R2B in murine and human adipocyte differentiation Presenter: Federica Ermetici F Ermetici; E Peverelli; G Mantovani; S Corbetta; L Avagliano; G Bulfamante; P Beck-Peccoz; A Spada;
12:30	OC1.6	Variation in response to exercise in type 2 diabetes associated to VEGFA and PGC1-alfa expression Presenter: Henrik Wagner H Wagner; H Fischer; M Degerblad; P Båvenholm; S Efendic; T Gustafsson;

13:00 14:30		Lunch & Exhibition ESE President Meets ESE Affiliated Society Presidents (Invitation Only - Meeting Hall V) Room: Exhibition Hall

13:00 15:30		Poster session: Talk to me!

13:00 14:30		Debate 1: When should we treat transsexualism / gender dysphoria? During Puberty: H. Delemarre-van de Waal (The Netherlands); After Puberty: G. T'Sjoen (Belgium) Room: Main Auditorium Chair: O. Hiort (Denmark)

13:00 14:00		Meet the Expert 1: Delayed puberty in boys Room: Forum Hall E. Malecka-Tendera (Poland)

13:00 14:00		Meet the Expert 2: Primary hyperaldosteronism Room: Meeting Hall I J. Widimsky (Czech Republic)

13:00 14:00		Meet the Expert 3: The expanding phenotype of adult Turner syndrome Room: Panorama Hall C. Gravholt (Denmark)

13:00 14:00		Meet the Expert 4: Disorders of sexual development (DSD) Room: Meeting Hall IV I. Hughes (UK)

14:30 15:30		Meet the Expert 5: How do you choose your treatment in inoperable pancreatic NET? Room: Forum Hall B. Kos-Kudla (Poland)

14:30 15:30		Meet the Expert 6: Management of Graves' ophthalmopathy Room: Meeting Hall I G. Krassas (Greece)

14:30 15:30		Meet the Expert 7: Cushing's Syndrome Room: Panorama Hall M. Boscaro (Italy)

14:30 15:30		Meet the Expert 8: Hyponatraemia: Diagnosis and novel treatments Room: Meeting Hall IV C. Thompson (Ireland)

15:30 17:00		Symposium 7: Approaches to preservation of gonadal function after cancer therapy Room: Main Auditorium Chairs: S. Christin-Maitre (France) & A. Milewicz (Poland)
15:30	S7.1	Ovarian transplantation C.Y. Anderson (Denmark)
16:00	S7.2	ART/IVF and cryopreservation M. von Wolff (Germany)
16:30	S7.3	Oocyte cryopreservation A. Borini (Italy)

15:30 17:00		Symposium 8: Endocrine tumours: new genes and association with syndromes Room: Forum Hall Chairs: J. Bertherat (France) & K. Pacak (Czech Republic)
15:30	S8.1	Pituitary adenoma predisposition caused by AIP germline mutations L. Aaltonen (Finland)
16:00	S8.2	New multiple endocrine neoplasias: endocrine tumours associated with gastrointestinal stromal tumours (GISTs) C. Stratakis (USA)
16:30	S8.3	Update on familial pituitary tumours: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma A. Beckers (Belgium)

15:30 17:00		Symposium 9: The role of oxidative stress in the development of the metabolic syndrome Room: Meeting Hall I Chairs: A. Sjoholm (Sweden) & C. Meier (Switzerland)
15:30	S9.1	Mitochondrial dysfunction and insulin resistance M. Roden (Germany)
16:00	S9.2	Macrophage dysfunction and insulin resistance P. Kovanen (Finland)
16:30	S9.3	Marked improvement of insulin resistance by reduced AGE intake; a non-pharmacologic, non-nutrient based intervention for type 2 diabetes H. Vlassara (USA)

15:30 17:00		Oral Communications 2: Thyroid Room: Panorama Hall Chairs: Z. Limanova (Czech Republic) & A. Gursoy (Turkey)
15:30	OC2.1	Calcitonin screening and pentagastrin testing: predictive value for diagnosis medullary carcinoma in nodular thyroid disease Presenter: Burkhard Herrmann B Herrmann; K Schmid; A Bockisch; M Kemen; K Mann;
15:45	OC2.2	Systemic sodium iodide symporter (NIS) gene transfer in hepatocellular carcinoma using EGF-receptor targeted non-viral gene delivery vectors Presenter: Kathrin Klutz K Klutz; D Schaffert; W Rödl; M JWillhauck; A Cengizeroglu; N Wunderlich; F JosefGildehaus; E Wagner; B Göke; M Ogris; C Spitzweg;
16:00	OC2.3	Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on Fine-Needle Aspiration Biopsies Presenter: Mattia Buratto M Buratto; F Tagliati; G Trasforini; S Leoni; R Rossi; E Uberti; M Zatelli;
16:15	OC2.4	Polyglandular autoimmunity in autoimmune thyroid disease behaves differently from polyglandular autoimmunity in type 1 diabetes Presenter: Janneke Wiebolt J Wiebolt; A den Boer; R Achterbergh; B Suelmann; S van der Leij; R de Vries; T van Haeften;
16:30	OC2.5	Thyroid dysfunction related abnormalities in adiponectin and glucose metabolism before and after treatment Presenter: Didem Ozdemir D Ozdemir; S Dagdelen; A Usman;
16:45	OC2.6	Percutaneous Laser Ablation (PLA) in non-functioning benign thyroid nodules: a 3-year follow-up study. Presenter: Roberto Valcavi R Valcavi; F Riganti; A Bertani; D Formisano; C Pacella;

17:00 17:15		Coffee Break and Exhibition Room: Exhibition Hall

17:15 18:00		Plenary Lecture 2 Room: Main Auditorium Chairs: J. Toppari (Finland) & E. Diamanti-Kanarakis (Greece)
17:15	PL2	Testicular dysgenesis and endocrine disruptors N. Skakkebaek (Denmark)

18:15 19:45		Satellite Symposium: Progress in the management of postmenopausal osteoporosis Sponsored by Amgen in collaboration with GSK Room: Panorama Hall Chairs: Peter Lakatos (Hungary) & Bente Langdahl (Denmark)
18:15		Welcome from the chairs Peter Lakatos & Bente Langdahl
18:20		Burden of osteoporosis: why to treat and whom to treat? Eugene McCloskey (UK)
18:45		RANK Ligand - from molecular discovery to a novel understanding of osteoporosis Lorenz Hofbauer (Germany)
19:10		RANK Ligand inhibition: the clinical evidence Silvano Adami (Italy)
19:35		Discussion
19:45		Close of meeting

18:15 19:45		Satellite Symposium: Improving medical care thanks to multi-targeted therapies Sponsored by Ipsen Room: Forum Hall Chairs: Ann Klibanski (USA) & Ezio Ghigo (Italy)

18:15 19:45		Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases Sponsored by Merck Serono Room: Meeting Hall I Chair: Josef Marek (Czech Republic)
18:15		Introduction Josef Marek (Czech Republic)
18:25		Cardiovascular impact of GH therapy in adult Gh deficient patients L. Sacca (Italy)
18:45		Can early levothyroxine treatment reduce the cardiovascular risk in subclinical hypothyroidism U. Feldt-Rasmussen (Denmark)
19:05		Cardiovascular benefit of metformine in adults with type 2 diabetes A. Morris (UK)
19:25		Questions & Answers